SHPH
NASD Shuttle Pharmaceuticals Holdings, Inc.$5.55 ↑ +0.00 (+0.00%) Trading Up from the previous close of $5.55, $0.20 below the day’s high of $5.75
- YTD change
- -69.17%
- vs 20-day SMA
- +46.90%
- vs 200-day SMA
- -31.71%
Price ranges
Price & Performance
+4.80 (+640.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $252,520.00
- SHPH is down 69% since the beginning of the year
- SHPH is down 87% over the past 12 months
- SHPH is up 59% over the past 1 month
- 0% of all SHPH investors are betting against SHPH
SHPH reads very good: price sits above one of the two key moving averages, the 12-month move is +26.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.06
- Last 5 days
- +37.38%
- vs 8-day SMA
- +34.67%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and is headquartered in Gaithersburg, MD.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.